Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V710 vaccine in patients scheduled for cardiothoracic surgery
NCT00518687Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Dec 2007
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of V710 in Staphylococcus aureus infection, sponsored by Merck & Co.. Started Dec 2007; status: terminated.
02
Drugs
V710
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00518687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00518687.